Mia Khalifa Makes Ozempic Confession

Former adult movie actor Mia Khalifa has admitted to leaning on the use of weight-loss drug Ozempic after a social media user praised her taut physique.

In recent years, celebrities and influencers have endorsed the drug as a fat-melting miracle; the hashtag #ozempic has amassed over a billion views on TikTok alone. Stars have stepped forward to publicly discuss their experiences with Ozempic, subsequently sparking wider public interest in the drug.

On April 20, Khalifa took to X, formerly Twitter to promote her accessories and lifestyle brand Sheytan. The image showed gold jewelry draped across her bikini-clad frame as she held her pet dog.

Captioning the image, which as of press time has garnered more than 850,000 views, Khalifa wrote that her products were "available in GREEN."

Mia Khalifa talks Ozempic
Mia Khalifa on February 28, 2024 in Paris. The former adult film star told a social media user that she has leaned on Ozempic after she was complimented on her body. Victor Boyko/Getty Images for Acne

The post caught the attention of an X user, who expressed admiration for Khalifa's body, writing in Spanish: "Why wasn't I born with that body. My God, what did it cost you!?"

Responding in candid fashion, Khalifa admitted to surgical and medicinal aid, commenting: "Baby I bought my t*** and I'm on Ozempic, I can tell you exactly what it costs."

Newsweek has contacted Khalifa via social media for comment.

Ozempic is an injectable prescription drug that is used to manage blood sugar levels in patients with type 2 diabetes. It is based on a naturally occurring human hormone called glucagon-like peptide 1 (GLP-1), which plays an important role in regulating appetite and blood sugar levels.

The active ingredient in Ozempic is a molecule called semaglutide, which acts as a GLP-1 agonist. In other words, it mimics the structure of GLP-1 and activates its receptors. Studies have shown that people with obesity are often less sensitive to the hormones that make them feel full. But by slowing gastric emptying, drugs like Ozempic can restore feelings of fullness in these patients.

Ozempic, manufactured by Danish multinational pharmaceutical company Novo Nordisk, is one of the brand names for semaglutide, which is also known as Wegovy. Unlike Ozempic, Wegovy—which is used off-label for weight loss—is specifically designed to treat obesity. Another popular drug is the tirzepatide Mounjaro, which works to reduce the appetite and better break down sugar and fat.

Elon Musk, Whoopi Goldberg, Sharon Osbourne, Amy Schumer, and Tracy Morgan are just some of the familiar names who have spoken about their experiences with taking Ozempic, both good and bad. Oprah Winfrey credited her recent weight loss to the use of an unnamed drug that had been prescribed to her.

Such is its ubiquity that comedian Chelsea Handler once shared in an interview that she didn't even know she was on the drug during the brief time she took it.

"My anti-aging doctor just hands it out to anybody," the former Chelsea Lately host said during her appearance on the Call Her Daddy podcast last year. "I didn't even know I was on it. She said, 'If you ever want to drop five pounds, this is good.'"

Handler, who eventually stopped taking Ozempic after it left her feeling "nauseous," added: "I realized I didn't want to use it because it was silly. It's for heavy people."

Sue Decotiis, a New York City-based medical weight loss doctor, recently told Newsweek that the drug's popularity is justified as it's "so highly effective, not just Ozempic but Mounjaro, which is the newer drug made by [pharmaceutical company] Eli Lilly. People have gotten such incredible results from these medications."

"This is the first time just about everybody has gotten results from a medication like this. It got incredible press for that reason, and it just took off because we obviously have a lot of obesity in this country. Even for individuals who are at a normal weight, but got older and their hormones change and they aren't able to lose weight on their own, these drugs come in and lose the weight for them," Decotiis said.

"It's not just about losing body fat and getting lean," she added. "When insulin is optimized, the drug has multisystem effects. There's less brain fog, less anxiety, stress, and there's just all-around widespread effects—decreased cardiovascular risks, heart failure. [These are the] overall positive effects that these medications bring."

Uncommon Knowledge

Newsweek is committed to challenging conventional wisdom and finding connections in the search for common ground.

Newsweek is committed to challenging conventional wisdom and finding connections in the search for common ground.

About the writer


Ryan Smith is a Newsweek Senior Pop Culture and Entertainment Reporter based in London, U.K. His focus is reporting on ... Read more

To read how Newsweek uses AI as a newsroom tool, Click here.

Newsweek cover
  • Newsweek magazine delivered to your door
  • Newsweek Voices: Diverse audio opinions
  • Enjoy ad-free browsing on Newsweek.com
  • Comment on articles
  • Newsweek app updates on-the-go
Newsweek cover
  • Newsweek Voices: Diverse audio opinions
  • Enjoy ad-free browsing on Newsweek.com
  • Comment on articles
  • Newsweek app updates on-the-go